Oliver P. Kronenberg, PhD, joined Santhera as Chief Legal Officer (CLO) and member of Santhera’s Executive Management Team effective August 1, 2024. Prior to his new role, he was Group General Counsel of Vifor Pharma and a member of its Executive Committee. In such role, he led significant M&A transactions, including the USD 12 billion acquisition of Vifor Pharma by CSL. He has extensive expertise in licensing transactions, antitrust law, corporate matters and litigations. Oliver started his career in the life science industry at Ferring Pharmaceuticals and Kuros Biosurgery.

Oliver, citizen of Switzerland, holds a Doctorate in Law from the University of Basel, a LLM degree from the College of Europe in Bruges, Belgium, and the Board Director diploma from the IMD in Lausanne.